Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0GNGAI
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
CN112341521B+ADC-23
|
|||||
| Synonyms |
CN112341521B+ADC-23
Click to Show/Hide
|
|||||
| Organization |
Jiangsu Hansoh Pharmaceutical Group Co Ltd; Shanghai Hansoh Biomedical Co Ltd
|
|||||
| Drug Status |
Investigative
|
|||||
| Drug-to-Antibody Ratio |
4.3
|
|||||
| Structure |
|
|||||
| Antibody Name |
Nimotuzumab
|
Antibody Info | ||||
| Antigen Name |
V-set domain-containing T-cell activation inhibitor 1 (VTCN1)
|
Antigen Info | ||||
| Payload Name |
Undisclosed
|
|||||
| Therapeutic Target |
Stimulator of interferon genes protein (STING1)
|
Target Info | ||||
| Linker Name |
CN112341521B+Linker22
|
Linker Info | ||||
| Conjugate Type |
Random conjugation through reduced inter-chain cysteines.
|
|||||
| Combination Type |
I-23
|
|||||